{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "product_ndc": "72122-004",
      "generic_name": "Ceftobiprole Medocaril Sodium for Injection",
      "labeler_name": "Nipro Pharma Corporation",
      "active_ingredients": [
        {
          "name": "CEFTOBIPROLE MEDOCARIL SODIUM",
          "strength": "500 mg/mL"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "72122-004-01",
          "description": "1 mL in 1 VIAL, GLASS (72122-004-01)",
          "marketing_start_date": "01-APR-25"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "45c049cd-c3ba-2c28-e063-6294a90a02eb",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20250401",
      "product_id": "72122-004_45c049cd-c3ba-2c28-e063-6294a90a02eb",
      "brand_name_base": null
    }
  ]
}